Observational Prospective Study OPTIMA II - Follow-up
NCT02099565
·
clinicaltrials.gov ↗
COMPLETED
Status
572
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
Sponsor
AstraZeneca